Status:
COMPLETED
A Multi-Center, Open-label Study Evaluate the Efficacy and Tolerability of a Dual Skincare Regimen Treatment for Facial Hyperpigmentation and Photodamaged Skin in Patients Exposed to Extrinsic Factors of Aging
Lead Sponsor:
Revision Skincare
Conditions:
Hyperpigmentation
Photodamaged Skin
Eligibility:
FEMALE
35-60 years
Phase:
NA
Brief Summary
This open-label, multi-center clinical trial was conducted to evaluate the dual skincare regimen of vitamin C serum and moisturizing sunscreen SPF 45 to improve facial hyperpigmentation and photodamag...
Detailed Description
This open-label, multi-center clinical trial was conducted to evaluate the dual skincare regimen of vitamin C serum and moisturizing sunscreen SPF 45 to improve facial hyperpigmentation and photodamag...
Eligibility Criteria
Inclusion
- Women between the ages of 35 and 60 years old.
- Women with Fitzpatrick skin type I-V.
- Subjects must have moderate to severe global face hyperpigmentation.
- Subjects must have moderate global face photodamage.
- Subjects must have no known medical conditions that, in the investigator's opinion, may interfere with study participation.
- Subjects must be willing to provide verbal understanding and written informed consent.
Exclusion
- Subjects which had a health condition and/or pre-existent dormant dermatological disease on the face.
- Subjects that are unwilling to comply with the protocol.
- Female subjects who are pregnant, breast feeding, or planning a pregnancy.
- Subjects who have demonstrated a previous hypersensitivity reaction to any of the ingredients of the study products.
- Subjects who have a history of skin cancer.
- Subjects who have observable suntan, sunburn, scars, nevi, tattoo, excess hair, etc. or other dermatological condition on the face that might influence the test results in the opinion of the investigator.
- Subjects who have routinely used any anti-aging, anti-wrinkles, antioxidants treatments and skin-firming products less than 30 days prior to the study entry.
Key Trial Info
Start Date :
March 17 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 10 2022
Estimated Enrollment :
33 Patients enrolled
Trial Details
Trial ID
NCT05423873
Start Date
March 17 2021
End Date
February 10 2022
Last Update
June 21 2022
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Art of Skin MD
Solana Beach, California, United States, 92075
2
About Skin
Greenwood Village, Colorado, United States, 80111
3
Brian S. Biesman, M.D.
Nashville, Tennessee, United States, 37203